Skip to main content
Figure 5 | Genome Medicine

Figure 5

From: Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings

Figure 5

Dynamic range of IPAS MS pointing to proteins validated by ELISA. (a) Correlation between spectral counts (number of tandem mass spectra (MS2) acquired per protein) and estimated/measured serum concentrations. (b) Cumulative protein identifications are plotted versus ELISA protein concentration determined by ELISA measurments (red) and estimated concentration (blue) as determined by spectral counts.

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us